This is in line with the retainment of IL-17+ CD8+ Tissue-resident memory (Trm) cells in clinically resolved psoriasis lesion, where they are poised to be reactivated42, and the beneficial effect of CD8 blockade in preventing psoriasis development in the AGR 129 xenotransplant model21. The gene discussed is CD8A; the disease is psoriasis.